Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of cell and gene therapy technologies has expanded its collaboration with Labcorp to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.

Through their collaboration, Labcorp and Xcellbio will work on a series of projects focused on improving the safety and efficacy of cell and gene therapies (CGTs), leveraging Xcellbio’s cell and gene therapy expertise and proprietary workflows

Press Release